In a first, FDA approves use of Apple Watch for clinical trials involving abnormal heartbeats May 3, 2024 by Washington Times The Food and Drug Administration has approved the use of the Apple Watch in clinical trials dealing with atrial fibrillation, a type of abnormal heartbeat.